Researchers at the UCLA Health Jonsson Comprehensive Cancer Center have used cells from sarcoma patients to develop the ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the ...

Pancreatic cancer is one of the deadliest cancers worldwide. A promising technology poised to advance treatment is organoids, ...

In this edition of the biotech bi-weekly, a new partnership takes vascularized organoids to the international space station ...

Stimulating a key metabolic pathway in T cells can make them work more effectively against tumors when combined with immune ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient ...

Investigators developed the largest collection of sarcoma patient-derived organoids to date that can help improve the understanding of the disease and better identify therapies that are most likely to ...

Investigators at the UCLA Health Jonsson Comprehensive Cancer Center have developed the largest collection of sarcoma patient ...

This article from Molecular Devices discusses how automated workflows can be leveraged to enable complex organoid assays.

Tempus AI has announced an expanded collaboration with Takeda to enhance oncology research and development. The partnership ...

The following is a summary of “Patient-derived Organoids in Bladder Cancer: Opportunities and Challenges,” published in the ...